- Home
- Publications
- Publication Search
- Publication Details
Title
Oncolytic viruses: focusing on the tumor microenvironment
Authors
Keywords
-
Journal
CANCER GENE THERAPY
Volume 22, Issue 4, Pages 169-171
Publisher
Springer Nature
Online
2015-02-27
DOI
10.1038/cgt.2015.11
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The addition of recombinant vaccinia HER2/neu to oncolytic vaccinia-GMCSF given into the tumor microenvironment overcomes MDSC-mediated immune escape and systemic anergy
- (2015) C R de Vries et al. CANCER GENE THERAPY
- Oncolytic viruses as platform for multimodal cancer therapeutics: a promising land
- (2014) Z S Guo et al. CANCER GENE THERAPY
- Localized Oncolytic Virotherapy Overcomes Systemic Tumor Resistance to Immune Checkpoint Blockade Immunotherapy
- (2014) D. Zamarin et al. Science Translational Medicine
- Poxviral-based vaccine elicits immunologic responses in prostate cancer patients
- (2014) Ravi A Madan et al. OncoImmunology
- Intratumoral injection of therapeutic HPV vaccinia vaccine following cisplatin enhances HPV-specific antitumor effects
- (2013) Sung Yong Lee et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Phase I study of intraprostatic vaccine administration in men with locally recurrent or progressive prostate cancer
- (2013) James L. Gulley et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Monocytic CCR2+ Myeloid-Derived Suppressor Cells Promote Immune Escape by Limiting Activated CD8 T-cell Infiltration into the Tumor Microenvironment
- (2011) A. M. Lesokhin et al. CANCER RESEARCH
- Measles virus causes immunogenic cell death in human melanoma
- (2011) O G Donnelly et al. GENE THERAPY
- Interleukin 10 in the tumor microenvironment: a target for anticancer immunotherapy
- (2011) Takami Sato et al. IMMUNOLOGIC RESEARCH
- Functional characterization of human Cd33+ And Cd11b+ myeloid-derived suppressor cell subsets induced from peripheral blood mononuclear cells co-cultured with a diverse set of human tumor cell lines
- (2011) Melissa G Lechner et al. Journal of Translational Medicine
- The Oncolytic Poxvirus JX-594 Selectively Replicates in and Destroys Cancer Cells Driven by Genetic Pathways Commonly Activated in Cancers
- (2011) Kelley A Parato et al. MOLECULAR THERAPY
- Intravenous delivery of a multi-mechanistic cancer-targeted oncolytic poxvirus in humans
- (2011) Caroline J. Breitbach et al. NATURE
- Local and Distant Immunity Induced by Intralesional Vaccination with an Oncolytic Herpes Virus Encoding GM-CSF in Patients with Stage IIIc and IV Melanoma
- (2009) Howard L. Kaufman et al. ANNALS OF SURGICAL ONCOLOGY
- Use of a targeted oncolytic poxvirus, JX-594, in patients with refractory primary or metastatic liver cancer: a phase I trial
- (2008) Byeong-Ho Park et al. LANCET ONCOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started